Chen and colleagues reported 80.56% of immunohistochemical reactivity of gastric cancer cells to bcl-2 protein which was irrespective to tumor location, histologic type of cancer, and lymph node metastasis status (11). This evidence concerns the gene BCL2 and cancer.